Role of Inflammatory Markers in Sepsis

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

January 5, 2025

Study Completion Date

January 25, 2025

Conditions
Diagnostic
Interventions
DIAGNOSTIC_TEST

Serology tests

CD4, CD25, IL17

Trial Locations (1)

11796

Walaa Y Elsabeeny, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT06111963 - Role of Inflammatory Markers in Sepsis | Biotech Hunter | Biotech Hunter